75 related articles for article (PubMed ID: 15140582)
1. Characterization of the postglomerular renal metabolism of lepirudin in healthy volunteers.
Kautzleben M; Stein G; Sperschneider H; Nowak G
Thromb Res; 2004; 113(3-4):187-95. PubMed ID: 15140582
[TBL] [Abstract][Full Text] [Related]
2. Characterization of C-terminal-truncated urinary metabolites of a recombinant hirudin in rats.
Komatsu Y; Hayashi H
Peptides; 1999 Dec; 20(12):1401-9. PubMed ID: 10698114
[TBL] [Abstract][Full Text] [Related]
3. Comparison of monitoring methods for lepirudin: impact of warfarin and lupus anticoagulant.
Salmela B; Joutsi-Korhonen L; Saarela E; Lassila R
Thromb Res; 2010 Jun; 125(6):538-44. PubMed ID: 20181379
[TBL] [Abstract][Full Text] [Related]
4. Sites of elimination and pharmacokinetics of recombinant [131I]lepirudin in baboons.
Meiring SM; Lötter MG; Badenhorst PN; Bucha E; Nowak G; Kotzé HF
J Pharm Sci; 1999 May; 88(5):523-9. PubMed ID: 10229643
[TBL] [Abstract][Full Text] [Related]
5. Successful use of recombinant hirudin and its monitoring by ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization.
Iqbal O; Tobu M; Aziz S; Gerdisch M; Da Valle M; Demir M; Hoppensteadt DA; Ahmad S; Walenga JM; Fareed J
J Card Surg; 2005; 20(1):42-51. PubMed ID: 15673409
[TBL] [Abstract][Full Text] [Related]
6. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
[TBL] [Abstract][Full Text] [Related]
7. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin activity of lepirudin adsorbed to silicone (polydimethylsiloxane) tubing.
Horne MK; Brokaw KJ
Thromb Res; 2003; 112(1-2):111-5. PubMed ID: 15013282
[No Abstract] [Full Text] [Related]
9. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
Fabrizio MC
J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
[TBL] [Abstract][Full Text] [Related]
10. [Removal of lepirudin used as an anticoagulant in mechanical autotransfusion with Cell-Saver 5].
Marx A; von Lüpke U; Tessmann R; Lindhoff-Last E
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):162-6. PubMed ID: 11324348
[TBL] [Abstract][Full Text] [Related]
11. Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis.
Willey ML; de Denus S; Spinler SA
Pharmacotherapy; 2002 Apr; 22(4):492-9. PubMed ID: 11939684
[TBL] [Abstract][Full Text] [Related]
12. Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.
Casserly IP; Kereiakes DJ; Gray WA; Gibson PH; Lauer MA; Reginelli JP; Moliterno DJ
Thromb Res; 2004; 113(2):115-21. PubMed ID: 15115666
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure.
Pöschel KA; Bucha E; Esslinger HU; Nörtersheuser P; Jansa U; Schindler S; Nowak G; Stein G
Kidney Int; 2000 Dec; 58(6):2478-84. PubMed ID: 11115081
[TBL] [Abstract][Full Text] [Related]
14. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
[TBL] [Abstract][Full Text] [Related]
15. Lepirudin anticoagulation for heparin-induced thrombocytopenia.
Deitcher SR; Topoulos AP; Bartholomew JR; Kichuk-Chrisant MR
J Pediatr; 2002 Feb; 140(2):264-6. PubMed ID: 11865285
[TBL] [Abstract][Full Text] [Related]
16. Rotational thrombelastometry for the bedside monitoring of recombinant hirudin.
Sucker C; Zotz RB; Görlinger K; Hartmann M
Acta Anaesthesiol Scand; 2008 Mar; 52(3):358-62. PubMed ID: 18205897
[TBL] [Abstract][Full Text] [Related]
17. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT
Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620
[TBL] [Abstract][Full Text] [Related]
18. Hirudin in renal insufficiency.
Fischer KG
Semin Thromb Hemost; 2002 Oct; 28(5):467-82. PubMed ID: 12420243
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin.
Eichler P; Lubenow N; Strobel U; Greinacher A
Blood; 2004 Jan; 103(2):613-6. PubMed ID: 14512301
[TBL] [Abstract][Full Text] [Related]
20. Purification and identification of recombinant hirudin and its degradation products expressed in Pichia pastoris.
Zhou WB; Zhang YX
Prep Biochem Biotechnol; 2004 Aug; 34(3):239-52. PubMed ID: 15461140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
